Formation of immune complexes and thrombotic microangiopathy after intravitreal injection of bevacizumab in the primate eye

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 250, Issue 9, 2012, Pages 1303-1313

  Schraermeyer, Ulrich ^a   Julien, Sylvie ^a  

^a Centre for Ophthalmology   (Germany)

Author keywords

Blood cells; Drugs; Thrombosis; Ultrastructure

Indexed keywords

BEVACIZUMAB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CHOROID CAPILLARY LAYER; CHOROID VASCULARIZATION; CONTROLLED STUDY; DRUG EFFECT; ELECTRON MICROSCOPY; ENDOTHELIUM; ENUCLEATION; EYE PHOTOGRAPHY; HAPLORHINI; NONHUMAN; OPHTHALMOSCOPY; PHOTORECEPTOR; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SWELLING; THROMBOCYTE; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; APOPTOSIS; BLOOD PLATELETS; CAPILLARIES; CELL DEGRANULATION; CHOROID; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IMMUNE COMPLEX DISEASES; INTRAVITREAL INJECTIONS; MACACA FASCICULARIS; MICROSCOPY, FLUORESCENCE; PHOTORECEPTOR CELLS, VERTEBRATE; PLATELET ACTIVATION; THROMBOTIC MICROANGIOPATHIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84866558151     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-012-2055-z     Document Type: Article

References (25)

1. Semenza GL (2008) A new weapon for attacking tumor blood vessels. N Engl J Med 358:2066-2067.
2. Scappaticci FA, Skillings JR, Holden SN, Gerber HP, Miller K, Kabbinavar F, Bergsland E, Ngai J, Holmgren E, Wang J, Hurwitz H (2007) Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab. J Natl Cancer Inst 99:1232-1239.
3. Vaughn C, Zhang L, Schiff D (2008) Reversible posterior leukoencephalopathy syndrome in cancer. Curr Oncol Rep 10:86-91.
4. Velcheti V, Viswanathan A, Govindan R (2006) The proportion of patients with metastatic non-small cell lung cancer potentially eligible for treatment with bevacizumab: A single institutional survey. J Thorac Oncol 1:501.
5. Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J, Richardson C, Kopp JB, Kabir MG, Backx PH, Gerber HP, Ferrara N, Barisoni L, Alpers CE, Quaggin SE (2008) Vegf inhibition and renal thrombotic microangiopathy. N Engl J Med 358:1129-1136.
6. Rosenfeld PJ, Moshfeghi AA, Puliafito CA (2005) Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 36:331-335.
7. Gunther JB, Altaweel MM (2009) Bevacizumab (Avastin) for the treatment of ocular disease. Surv Ophthalmol 54:372-400.
8. Heiduschka P, Fietz H, Hofmeister S, Schultheiss S, Mack AF, Peters S, Ziemssen F, Niggemann B, Julien S, Bartz-Schmidt KU, Schraermeyer U (2007) Penetration of bevacizumab through the retina after intravitreal injection in the monkey. Invest Ophthalmol Vis Sci 48:2814-2823.
9. Peters S, Heiduschka P, Julien S, Ziemssen F, Fietz H, Bartz- Schmidt KU, Schraermeyer U (2007) Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab. Am J Ophthalmol 143:995-1002.
10. Meyer T, Robles-Carrillo L, Robson T, Langer F, Desai H, Davila M, Amaya M, Francis JL, Amirkhosravi A (2009) Bevacizumab immune complexes activate platelets and induce thrombosis in fcgr2a transgenic mice. J Thromb Haemost 7:171-181.
11. Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ (2011) Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 364: 1897-1908.
12. Carneiro AM, Barthelmes D, Falcao MS, Mendonca LS, Fonseca SL, Goncalves RM, Faria-Correia F, Falcao-Reis FM (2011) Arterial thromboembolic events in patients with exudative age-related macular degeneration treated with intravitreal bevacizumab or ranibizumab. Ophthalmologica 225:211-221.
13. Nguyen DC, Scinicariello F, Attanasio R (2011) Characterization and allelic polymorphisms of rhesus macaque (macaca mulatta) igg fc receptor genes. Immunogenetics 63:351-362.
14. Carstairs KC (1965) The identification of platelets and platelet antigens in histological sections. J Pathol Bacteriol 90:225-231.
15. Nickla DL, Wallman J (2010) The multifunctional choroid. Prog Retin Eye Res 29:144-168.
16. Blaauwgeers HG, Holtkamp GM, Rutten H, Witmer AN, Koolwijk P, Partanen TA, Alitalo K, Kroon ME, Kijlstra A, van Hinsbergh VW, Schlingemann RO (1999) Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am J Pathol 155:421-428.
17. Julien S, Schraermeyer U (2012) Lipofuscin can be eliminated from the retinal pigment epithelium of monkeys. Neurobiol Aging [Epub ahead of print].
18. Joseph R, Riddle JM, Welch KM, D'Andrea G (1989) Platelet ultrastructure and secretion in acute ischemic stroke. Stroke 20: 1316-1319.
19. Boros P, Odin JA, Muryoi T, Masur SK, Bona C, Unkeless JC (1991) Igm anti-fc gamma r autoantibodies trigger neutrophil degranulation. J Exp Med 173:1473-1482.
20. Cleary CA, Sharaznayan D, Hickey-Dwyer M (2011) Intravitreal anti-vegf therapy for neovascular age-related macular degeneration and the risk of stroke. Ir Med J 104:146-149.
21. Rasier R, Artunay O, Yuzbasioglu E, Sengul A, Bahcecioglu H (2009) The effect of intravitreal bevacizumab (avastin) administration on systemic hypertension. Eye 23:1714-1718.
22. Fontaine O, Olivier S, Descovich D, Cordahi G, Vaucher E, Lesk MR (2011) The effect of intravitreal injection of bevacizumab on retinal circulation in patients with neovascular macular degeneration. Invest Ophthalmol Vis Sci 52:7400-7405.
23. Barak A, Burgansky-Eliash Z, Barash H, Nelson DA, Grinvald A, Loewenstein A (2011) The effect of intravitreal bevacizumab (avastin) injection on retinal blood flow velocity in patients with choroidal neovascularization. Eur J Ophthalmol [Epub ahead of print]. doi:10.5301/ejo.5000074.
24. von Hanno T, Kinge B, Fossen K (2010) Retinal artery occlusion following intravitreal anti-vegf therapy. Acta Ophthalmol 88:263-266.
25. Hosseini H, Lotfi M, Esfahani MH, Nassiri N, Khalili MR, Razeghinejad MR, Nouri-Mahdavi K (2012) Effect of intravitreal bevacizumab on retrobulbar blood flow in injected and uninjected fellow eyes of patients with neovascular age-related macular degeneration. Retina 32(5):967-971.